InsidersTradesSigma
Explore the complete record of transactions filed by Danos Olivier, Directeur Scientifique. Officer active across 1 companies, notably REGENXBIO Inc.. In total, 2 filings have been logged. The latest transaction was disclosed on 30 June 2021 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
2 of 2 declarations
Olivier Danos is the Chief Scientific Officer at REGENXBIO Inc., a biopharmaceutical company specializing in gene therapy. He is responsible for research and development of new therapies. His role is crucial in driving innovation and ensuring the effectiveness of developed products.